You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pembrolizumab

Showing 2026 - 2041 of 2,041
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Trial in Seoul (MCS110/PDR001 combination)

Unknown status
  • Gastric Cancer
  • MCS110/PDR001 combination
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 8, 2019

NSCLC Stage IIIB, NSCLC Stage IV, EGFR Activating Mutation Trial in Hong Kong (Atezolizumab, Bevacizumab, Carboplatin)

Unknown status
  • NSCLC Stage IIIB
  • +2 more
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Apr 16, 2019

Tumor, Solid, Lymphoma Trial in Beijing (GR1405 injection)

Unknown status
  • Tumor, Solid
  • Lymphoma
  • GR1405 injection
  • Beijing, China
    Cancer Institute/Hospital, Chinese Academy of Medical Sciences &
Nov 4, 2018

Squamous Cell Anal Carcinoma Trial in Padova (Avelumab, Cetuximab)

Unknown status
  • Squamous Cell Anal Carcinoma
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Jul 25, 2019

Nonsmall Cell Lung Cancer Trial in Villejuif (Atezolizumab)

Recruiting
  • Nonsmall Cell Lung Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jan 2, 2019

Renal Cell Carcinoma Trial in Amsterdam (Axitinib, Avelumab)

Recruiting
  • Renal Cell Carcinoma
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
May 18, 2018

Primary CNS Lymphoma Trial in Vienna (pembrolizumab)

Unknown status
  • Primary Central Nervous System Lymphoma
  • pembrolizumab
  • Vienna, Austria
    Dept of Internal Medicine
Jun 21, 2016

Breast Tumors, Bone Tumors Trial in Melbourne (Stereotactic Ablative Body Radiosurgery (SABR), MK-3475)

Completed
  • Breast Neoplasms
  • Bone Neoplasms
  • Stereotactic Ablative Body Radiosurgery (SABR)
  • MK-3475
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Oct 17, 2017

HIV Infected Patients With Cancer Treated by ICPi Trial in France (Blood sample)

Unknown status
  • HIV Infected Patients With Cancer Treated by ICPi
  • Blood sample
  • La Réunion, Saint-Denis, France
  • +55 more
Jan 24, 2018

Melanoma Trial in Pittsburgh (High dose bolus interleukin-2 (HD IL2))

Terminated
Has Results
  • Melanoma
  • High dose bolus interleukin-2 (HD IL2)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center- Hillman Cancer Center
Mar 21, 2018

MMR Status and PD-L1 Expression Using Specimens Obtained by

Unknown status
  • Pancreatic Cancer
  • EUS-FNB
  • Immunohistochemistry
  • (no location specified)
Jan 27, 2019

NSCLC Trial (Durvalumab, Tremelimumab)

Withdrawn
  • Non-small Cell Lung Cancer
  • (no location specified)
Dec 4, 2017

Metastatic Melanoma Trial in Pittsburgh (Vaccination)

Terminated
Has Results
  • Metastatic Melanoma
  • Vaccination
  • Pittsburgh, Pennsylvania
    Upmc Upci Hcc
Jul 16, 2017

Multi-Centre, Retrospective, Open Label Study, to Validate

Unknown status
  • Melanoma
  • ML-PrediCare
  • Bene-Atarot, Israel
    Optimata Ltd.
Sep 26, 2016

Local Metastatic Melanoma Trial in France (DT01)

Completed
  • Local Metastatic Melanoma
  • Bordeaux, France
  • +11 more
Jun 16, 2016

Definition ofImmune Signature Predictive of Anti-PD1 Antibody in

Unknown status
  • Malignant Melanoma
  • Biopsies
  • (no location specified)
Oct 24, 2016